A collaborative intervention model involving a clinical pharmacist significantly reduces severe hypoglycemia risk without compromising glycemic control.

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

Strategic collaboration formed to raise awareness that all people with diabetes on blood glucose-lowering medications should have glucagon, preferable a ready-to-use formulation CHICAGO and ARLINGTON, ...

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...

Medications for type 2 diabetes address different aspects of blood sugar management and are tailored to individual health needs. Navigating type 2 diabetes treatment options can be complex, but ...

Fortunately, carefully managing your diabetes, reaching certain health targets, and making healthy lifestyle adjustments can all reduce the impact of type 2 diabetes on your lifespan, potentially ...

As patients transition to geriatric care, considerations about treatment-related side effects, polypharmacy, comorbidities, and life expectancy become paramount. This is especially true for older ...